Trevena, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • TRV045
    • TRV250
    • TRV734
  • Products
    • OLINVYK™ (oliceridine) injection
  • Medical Affairs
    • Investigator-Initiated Trials
    • Contact Medical Information
  • Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial Info
    • Stock Info
    • Resources
    • Governance
  • Careers
  • Contact
    • Contact Medical Information
    • Whistleblower Hotline

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events & Presentations
    • Presentations
    • IR Calendar
  • Financial Info
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Stock Info
    • Quote
    • Analyst Coverage
    • IRS Form 8937
  • Resources
    • Email Alerts
    • Contacts
    • FAQ
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Governance Documents

Trevena to Release Fourth Quarter and Full Year 2020 Financial Results on March 9, 2021

Mar 05, 2021 7:00am EST

Trevena, Inc. to Participate in March Virtual Investor Conferences

Mar 01, 2021 7:00am EST

Trevena, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Feb 22, 2021 7:00am EST

Trevena, Inc. Announces Publication Highlighting OLINVYK™ Respiratory Safety Data in High-Risk Patients in Pain & Therapy

Jan 28, 2021 7:00am EST

Trevena, Inc. to Participate in Two Upcoming Virtual Investor Conferences

Jan 07, 2021 7:00am EST

Trevena, Inc. Provides Update on Commercial Launch Activities for OLINVYK™ and Announces Anticipated Pipeline Catalysts

Jan 06, 2021 7:00am EST

Trevena, Inc. Announces Presentations Highlighting Novel S1P1 Receptor Modulator at the American College of Neuropsychopharmacology 59th Annual Meeting

Dec 10, 2020 8:43am EST

Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy

Nov 20, 2020 7:00am EST

Trevena, Inc. to Participate in the Following November Virtual Investor Conferences

Nov 09, 2020 7:00am EST

Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection

Oct 30, 2020 7:44am EDT
RSS
  • Prev
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...31
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed
    © 2023 Trevena, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Disclaimer Sitemap